Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
12 Feb 2026
Pandemic Linked to Reduced Cancer Survival Rates
A large US registry study found significantly worse one year cancer survival during 2020 and 2021, with an estimated 17 390 excess deaths linked to COVID-19 pandemic disruptions in care.
12 Feb 2026
Time-of-Day Immunochemotherapy Improves NSCLC Survival
Retrospective signals have suggested that treatment timing may influence immunochemotherapy efficacy, but prospective evidence has been limited.
12 Feb 2026
Fast Five: Alina Sturdza on Radiation Oncology Updates
In this episode, Alina Sturdza, Radiation Oncologist, shares her perspective on pivotal developments in radiation oncology from ESMO 2025…
12 Feb 2026
Vunakizumab Discontinuation Predicts Plaque Psoriasis Remission
After vunakizumab discontinuation, many plaque psoriasis patients maintained PASI 90, but BMI and interruptions predicted relapses.
12 Feb 2026
More Can Be Done To Optimize TGCT Patient Care
Optimising patient care in TGCT: Clinical subgroups, disease burden, diagnostic pathways and common management challenges…
4
Mins
12 Feb 2026
Interview with Frank Tacke: Rethinking Hepatic Inflammation
The field of liver research has benefited enormously from technological breakthroughs. We now have access to single-cell sequencing…
11
Mins
12 Feb 2026
Biosimilar natalizumab
Experts Simon Thebault and Thomas Berger discuss the impact of biosimilars in MS, in light of the approval of biosimilar-natalizumab…
11 Feb 2026
Psychotic Experiences Linked to Early Brain Ageing
New research links psychotic experiences to early brain ageing, offering clues about psychosis risk in young adults.
Bayer launches global women’s health campaign
Bayer and VML Health have launched a campaign challenging the tendency to normalise pain in women’s health.
11 Feb 2026
tRNA Fragment Shown to Protect Skin Against Photoageing
New research identifies a tRNA-derived RNA fragment that protects skin from UV-induced photoageing by preserving collagen and stabilising key mRNAs.
←
1
2
3
…
22
23
24
25
26
27
28
…
1,504
1,505
1,506
→
We’ve noticed you’re accessing
from
North/South America.
View
View